The role of magnesium in the treatment of symptoms climacteric syndrome

According to epidemiological studies, about 30% of residents in Russia receive less than 70% of the daily magnesium intake, while magnesium deficiency manifests much more often in women than in men. The prevalence of magnesium deficiency is 1.3 times higher among the female population. Women are mor...

Full description

Bibliographic Details
Main Authors: A. Z. Khashukoeva, Z. A. Agaeva, M. I. Agaeva, T. N. Sukhova, G. G. Moseshvili, Zh. K. Nurbekova
Format: Article
Language:Russian
Published: Remedium Group LLC 2019-01-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/2832
Description
Summary:According to epidemiological studies, about 30% of residents in Russia receive less than 70% of the daily magnesium intake, while magnesium deficiency manifests much more often in women than in men. The prevalence of magnesium deficiency is 1.3 times higher among the female population. Women are more sensitive to magnesium deficiency and normally have higher deposited concentrations of this element. Objective of the study: evaluate the effectiveness of magnesium in the management of menopausal syndrome symptoms. Materials and methods: 30 female patients, aged 47 to 57 years, with various menopausal syndrome symptoms underwent clinical and laboratory examination. In addition to the general clinical examination, all patients underwent atomic absorption spectroscopy to determine serum Mg2+ ions concentrations. All patients received menopausal hormone therapy in combination with magnesium supplement using Magnesium Diasporal 300. Results and discussions: The severe climacteric symptoms relief and an increase in the serum magnesium levels were recorded against the background of the therapy.
ISSN:2079-701X
2658-5790